Compare Ginkgo Bioworks Holdings Inc (DNA) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Lowe`s Companies Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $11.78 (market cap $763.64M), while Lowe`s Companies Inc trades at $186.47 (market cap $105.96B). The key difference: Lowe`s Companies Inc is far larger — about 138.8× Ginkgo Bioworks Holdings Inc's market cap, and Lowe`s Companies Inc pays a 2.65% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Lowe`s Companies Inc for 98 Days on average.
| DNA | LOW | |
|---|---|---|
Market Cap | $763.64M | $105.96B |
Volume | 3,204,177 | 4,039,547 |
Sector | Health | Consumer Cyclical |
52-Week High | $15.83 | $287.39 |
52-Week Low | $5.48 | $179.50 |
Typical Hold Time | 7 Days | 98 Days |
Enterprise Value | $865.59M | $144.81B |
Dividend Yield | — | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.47, down 7.57% today, reflecting ongoing volatility. The stock shows a bullish technical signal with strong moving average support, but fundamentals reveal significant challenges: revenue declined to $170.16M in 2025 with a net loss of $312.76M, and negative cash flow persists. Recent news includes a partnership with TuneLab for AI-driven drug discovery and a $17.5M ARPA-H subcontract for RNA medicine manufacturing, indicating strategic growth initiatives amid financial headwinds.
The outlook remains high-risk due to persistent losses and cash burn, though analyst sentiment is split evenly between buy, hold, and sell. Upside potential hinges on successful commercialization of its platform and cost management, while downside risks include execution missteps and prolonged profitability challenges. Investors should weigh the company's innovative partnerships against its weak financial metrics.
Lowe's (LOW) trades at $181.54, down 1.17% on the day, with a bearish technical signal and recent price weakness amid a slowing home improvement market. The company has beaten earnings estimates for the last three quarters, with a P/E of 15.96 and net income margin of 7.35%. Recent news highlights drone delivery tests with DoorDash and Alphabet, while cash flow improved in 2025 but is projected to decline in 2026.
The stock offers value with a consensus price target of $244.09, implying 34% upside, supported by a 60.79% buy rating from analysts. Risks include high debt levels, competitive pressure from Home Depot, and sensitivity to housing market trends. The current technical setup suggests near-term support at $179, with potential for a rebound if fundamentals hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
